Blood pressure hypothyroidism

Chronic hepatitis was reported in a 58-year-old woman with a history of high blood pressure, hypothyroidism, diabetes, and high cholesterol. The woman had been taking 80 mg of black cohosh extract daily for 1 year along with irbesartan, levothyroxin, simvastatin, and insulin. The liver injury was initially thought to be induced by simvastatin, although discontinuation of simvastatin did not result in a reduction of liver enzyme levels (Pierard et al. 2009). 

Disulfiram works by irreversibly blocking the enzyme aldehyde dehydrogenase, a step in the metabolism of alcohol, resulting in increased blood levels of the toxic metabolite acetaldehyde. As levels of acetaldehyde increase, the patient experiences decreased blood pressure, increased heart rate, chest pain, palpitations, dizziness, flushing, sweating, weakness, nausea and vomiting, headache, shortness of breath, blurred vision, and syncope. These effects are commonly referred to as the disulfiram-ethanol reaction. Their severity increases with the amount of alcohol that is consumed, and they may warrant emergency treatment. Disulfiram is contraindicated in patients who have cardiovascular or cerebrovascular disease, because the hypotensive effects of the disulfiram-alcohol reaction could be fatal in such patients or in combination with antihypertensive medications. Disulfiram is relatively contraindicated in patients with diabetes, hypothyroidism, epilepsy, liver disease, and kidney disease as well as impulsively suicidal patients. 

Kelling et al. (1987) assessed the effects of 2,3,7,8-TCDD on cardiac function tests in male Sprague-Dawley rats 7 days after single oral doses of 6.25, 25, or 100 g/kg. At 100 g/kg (near-lethal dose), an increased sensitivity to the inotropic (left atrium) and chronotropic (right atrium) effects of isoproterenol were observed. Three daily oral doses of 40 g/kg caused decreased heart rate, depressed blood pressure, and increased myocardial peroxidase activity in rats (Hermansky et al. 1988). All of these effects may have been secondary to the modulation of adenylate cyclase activity at -adrenergenic receptors as a result of hypothyroidism (Hermansky et al. 1987). 

In patients with hypothyroidism, the stimulatory effect of thyroid hormone on the oxidation of fuels is diminished. As a consequence, the generation of ATP is reduced, causing a sense of weakness, fatigue, and hypokinesis. The reduced metabolic rate is associated with diminished heat production, causing cold intolerance and decreased sweating. With less demand for the delivery of fuels and oxygen to peripheral tissues, the circulation is slowed, causing a reduction in heart rate and, when far advanced, a reduction in blood pressure. 

Figure 109.6 Relationships between diastolic blood pressure, noradrenaline, adrenocorticosteroid and free T3 (fT3) levels during the euthyroid and hypothyroid state. Correlations between daytime, diastolic blood pressure measured by 24h BP monitoring (a), noradrenaline (b), aldosterone (c), cortisol (d), and fT3 in 12 normotensive thyroidectomized patients during replacement therapy with synthetic L-T4 and 6 weeks after the withdrawal of L-T4. Experimental data from Fommei and lervasi (2002). ALDO Aldosterone CORT Cortisol DBP Diastolic BP NA Noradrenaline...

The manufacturing of hormonal products and medications to treat hormonal disorders is a significant segment of the pharmaceutical industry. Patients with chronic conditions, such as diabetes and hypothyroidism, are lifelong consumers. Many women take hormonal medications to deal with menopausal symptoms or dysmenorrhea (painful menstruation), and many use hormonal contraceptives (piUs, patches, or VE inal rings). In addition to hormonal products, many pharmaceuticals are designed to treat endocrine problems. These include medications to boost enei, aid in weight loss, induce sleep, and lower blood pressure. 

---